Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enzymatic Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN117467631B reveals novel P450 mutant for gamma-lactone. Enables cost reduction in fine chemical manufacturing with high selectivity.
Patent CN100344766C details a cost-effective enzymatic resolution of 2-methyl-1-butanol using vinyl acetate, offering significant supply chain advantages for pharmaceutical intermediates.
Patent CN112877386B details a novel enzymatic route for NMN. This report analyzes cost reduction in nutritional ingredients manufacturing and supply chain reliability.
Patent CN106906192A reveals high-efficiency microbial glucosyltransferase for crocetin ester synthesis. Offers superior yield and supply chain stability for pharmaceutical intermediates.
Novel carbonyl reductase mutants enhance thermal stability and yield for pharmaceutical intermediates like florfenicol and statins, offering cost-effective biocatalytic solutions.
Patent CN103555807B reveals one-step enzymatic route for 7-ACA. Offers high purity, reduced waste, and cost-effective supply chain solutions for global buyers.
Patent CN116515782A reveals a novel amine dehydrogenase mutant for high-purity chiral amine alcohol production, offering significant cost and safety advantages.
Patent CN108949736B reveals a novel PGA mutant for cephradine synthesis, offering superior Vs/Vh ratios and reduced hydrolysis for efficient API manufacturing.
Patent CN110551771A reveals green enzymatic synthesis using 1,3-butanediol. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN104328150B reveals continuous enzymatic synthesis. High yield, reduced cost, reliable supply chain for pharmaceutical intermediates manufacturing.
Patent CN118726291A reveals high-efficiency GluDH mutant for L-Glufosinate. Reduces cost, improves purity, and ensures supply chain reliability.
Patent CN109136311B reveals cost-effective SAM production. Adenosine substrate replaces ATP. Reliable supplier for pharma intermediates.
Patent CN119101667B reveals advanced enzyme fusion for ergothioneine. Discover cost reduction and supply chain reliability for nutritional ingredient manufacturing.
Patent CN110387359B discloses engineered enzymes for efficient statin production, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN101085990A reveals chemo-enzymatic route for high-purity chiral alcohols. Enables cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN101717810A enables efficient D-serine and L-tryptophan co-production. Discover cost reduction and supply chain advantages for pharmaceutical intermediates manufacturing.
Analysis of patent CN101085990B reveals a chemo-enzymatic route for high-purity chiral alcohols. This method offers significant supply chain stability and cost reduction advantages for pharmaceutical intermediate manufacturing.
Patent CN105154513A analysis reveals dynamic kinetic resolution for high-purity chiral intermediates. Achieve substantial cost reduction and supply chain reliability.
Patent CN111763703B reveals a novel DMF-based enzymatic route for sucrose-6-ethyl ester, offering higher yields and greener processing for reliable sweetener intermediate supply chains.
Novel dihydroorotase method for alpha-aspartyl peptides. Reduces racemization, simplifies purification. Ideal for sweetener and pharma intermediate manufacturing.